Back
Kymera Therapeutics, Inc. 10K Form
Buy
68
KYMR
Kymera Therapeutics, Inc.
Last Price:
$90.10
Seasonality Move:
-21.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive KYMR News And Ratings
See the #1 stock for the next 7 days that we like better than KYMR
KYMR Financial Statistics
Sales & Book Value
| Annual Sales: | $39.2M |
|---|---|
| Cash Flow: | $-66.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $19.42 |
| Price / Book: | 4.16 |
Profitability
| EPS (TTM): | -3.67930 |
|---|---|
| Net Income (TTM): | $-311.4M |
| Gross Margin: | $30.9M |
| Return on Equity: | -30.41% |
| Return on Assets: | -26.51% |
Kymera Therapeutics, Inc. Earnings Forecast
Key Kymera Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 8 years for KYMR is 78.80%.
-
The Selling, General & Administrative Expenses for KYMR have been equal to 173.90% of Gross Profit Margin.
-
The Research & Development expenses have been 786.14% of Revenue.
-
The Net Earning history of KYMR is -794.04% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 2 years.
Kymera Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | KYMR |
| Website: | kymeratx.com |
Debt
| Debt-to-Equity Ratio: | 0.05 |
|---|---|
| Current Ratio: | 10.47 |
| Quick Ratio: | 10.19 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
KYMR Technical Analysis vs Fundamental Analysis
Buy
68
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy or a Sell?
-
Kymera Therapeutics, Inc. stock is rated a BuyThe current Kymera Therapeutics, Inc. [KYMR] share price is $91.35. The Score for KYMR is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.